Navigation Links
Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 First Quarter Financial Results
Date:7/31/2008

HOUSTON, July 31 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that the company will report financial results for the first quarter ended July 25, 2008 of its fiscal year ending April 24, 2009 on Thursday, August 21, 2008 at 8:00 AM EDT. The company will conduct a conference call to discuss those results on the same day at 9:00 AM EDT.

Fiscal Year 2009 First Quarter Results Conference Call Instructions

To listen to the conference call live by telephone dial 877-313-8035 (if dialing from within the U.S.) or 706-679-4838 (if dialing from outside the U.S.). The conference ID is 58333036; the leader is Dan Moore. Presentation slides will be available on-line at http://www.cyberonics.com by 8:00 AM EDT on Thursday, August 21, 2008. A replay of the conference call will be available approximately two hours after the completion of the live call by dialing 800-642-1687 (if dialing from within the U.S.) or 706-645-9291 (if dialing outside the U.S.). The replay conference ID access code is 58333036.

About Cyberonics, Inc. and VNS Therapy(TM)

Cyberonics, Inc. (Nasdaq: CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy(TM) System, which is FDA-approved for the treatments of epilepsy and depression. The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics and VNS Therapy is available at http://www.cyberonics.com and http://www.vnstherapy.com.

CONTACT INFORMATION:

Greg Browne, CFO

Cyberonics, Inc.

100 Cyberonics Blvd.

Houston, TX 77058

Main: (281) 228-7262

Fax: (281) 218-9332

ir@cyberonics.com


'/>"/>
SOURCE Cyberonics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Cyberonics to Present at Collins Stewart Fourth Annual Growth Conference
2. Cyberonics Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2008 Financial Results
3. Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
4. Cyberonics Announces Conference Call to Discuss FY08 Q3 Financial Results
5. Cyberonics Licenses Obesity-Related Patents
6. VA Announces New Nursing Academy Sites
7. AdCare Health Systems, Inc. Announces the Refinancing of a Nursing Home in Ohio
8. Nuvo announces second quarter 2008 financial results
9. NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008
10. Cardiva Medical Announces Presentation at BMO Capital Markets 2008 Focus on Healthcare Conference
11. Lyriana Announces Antidepressants Now Linked to Declining Libido in Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... ... How to Write Error Free Procedures, **Presented by Ginette M. Collazo and ... known to be the major cause of quality and production losses in many industries. ... performance problems can be prevented. , How to Write Error Free Procedures, part two ...
(Date:5/24/2016)... CA (PRWEB) , ... May 24, 2016 , ... Loma ... house the new adult hospital and expanded Children’s Hospital. Over 3,000 people looked on ... , Check out the event photo slidehsow. , During the program, Richard ...
(Date:5/24/2016)... , ... May 24, 2016 , ... ... freezing, today announced the official relaunch of its community and education hub for ... eggs. Eggsurance's mission is to create a safe and welcoming place for women ...
(Date:5/24/2016)... , ... May 24, 2016 , ... Tuesday, May 24, ... The Yoga practice enhanced with Young Living Essential Oils, taught by Patti Dolan, RYT, ... the Lake Orion location. Yoga Flow is 6:30pm - 7:15pm followed by a small ...
(Date:5/24/2016)... DeLand, Florida (PRWEB) , ... May 24, 2016 , ... ... to make residents aware of the potential of contaminated well water throughout the Houston ... is homes supplied with well water that’s exposed to contaminants. Residents may not even ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... May 24, 2016 Celsion Corporation (NASDAQ: ... company, today provided an update on its ongoing ... trial combining GEN-1, the Company,s DNA-based immunotherapy, with ... newly-diagnosed patients with advanced ovarian cancer who will ... GEN-1 is an IL-12 DNA plasmid vector formulated ...
(Date:5/24/2016)... 24, 2016 The innovator ... , s first dual therapy stent, introduces ... OrbusNeich, a global company specializing in the ... to include products to treat peripheral artery disease. The ... entry devices for lower limb and arteriovenous (AV) fistula ...
(Date:5/24/2016)... 24, 2016 ... , la première endoprothèse à double thérapie ... l,intervention portant sur les membres inférieurs et ... OrbusNeich, entreprise mondiale spécialisée dans la fourniture ... vie, a élargi son portefeuille pour inclure ...
Breaking Medicine Technology: